ºÚÁÏÉç

Positions Available

It is anticipated that several other positions will become available in the foreseeable future in addition to the positions which are already posted. For those interested in learning more about the upcoming positions at our ºÚÁÏÉç teaching hospitals, please contact the following department chiefs:

Dr. Karine Igartua, Chief Department of Psychiatry, MUHC at karine.josee.igartua.med [at] ssss.gouv.qc.ca.

Dr. Karl Looper, Chief Department of Psychiatry, Jewish General Hospital at karl.looper.med [at] ssss.gouv.qc.ca

Dr. Gustavo Turecki, Chief Department of Psychiatry, CIUSSS Ouest-de-l'Île-de-Montréal (Douglas Institute and St-Mary’s Hospital) at chair.psychiatry [at] mcgill.ca

Dr. Eva-Flores Bui-Xuan, Chief Department of Psychiatry, Montreal Children's Hospital at efbx.med [at] ssss.gouv.qc.ca

Assistant Professor (Clinical), Department of Psychiatry, Refractory Schizophrenia (C2-250826)

The ºÚÁÏÉç Department of Psychiatry in the Faculty of Medicine and Health Sciences and the Douglas Mental Health University Institute are currently inviting applications for a full-time position as member of the Contract Academic Staff at the rank of Assistant Professor (Clinical).ÌýThe successful candidate will be involved in the academic activities of the ºÚÁÏÉç Department of Psychiatry. The incumbent will care for patients suffering from refractory schizophrenia, both inpatient and outpatient, in an innovative approach aimed at developing new therapeutic avenues.

Applications must be submitted on-line

Professeur(e) adjoint(e) (milieu clinique), Département de psychiatrie, schizophrénie réfractaire (C2-250826)

Le Département de psychiatrie de l’Université ºÚÁÏÉç de la Faculté de médecine et des sciences de la santé et l’Institut universitaire en santé mentale Douglas sont à la recherche de candidatures pour un poste à temps plein en tant membre du corps professoral contractuel, niveau professeur adjoint (en milieu clinique).ÌýLa candidature retenue prendra en charge des patients souffrant de schizophrénie réfractaire, aussi bien à l’interne qu’à l’externe, dans une approche novatrice visant à développer de nouvelles pistes thérapeutiques.

Les candidatures doivent être soumises en ligne

Ìý

Back to top